In the article “Application of Topical Phosphodiesterase 4 Inhibitors in Mild to Moderate Atopic Dermatitis: A Systematic Review and Meta-analysis” by Yang et al1 published in JAMA Dermatology on March 27, 2019, there was an error in the description of a study that was included in the meta-analysis. In the Discussion section, the authors incorrectly described that the study by Paller et al used the Children’s Dermatology Life Quality Index and the Dermatology Life Quality Index, when in fact the study used a 4-point scale. This error does not affect the conclusions of the meta-analysis. The article has been corrected online.
Reference
- 1.Yang H, Wang J, Zhang X, et al. Application of topical phosphodiesterase 4 inhibitors in mild to moderate atopic dermatitis: a systematic review and meta-analysis [published online March 27, 2019]. JAMA Dermatol. doi: 10.1001/jamadermatol.2019.0008. [DOI] [PMC free article] [PubMed] [Google Scholar]